GlobeNewsWire
22 Sept 2026, 20:50 UTC · 58m ago
Verdict
Headline takes no side. We score GUTS −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 2 new · 1 priced in
Pomerantz LLP has filed a class action lawsuit against Fractyl Health and its officers alleging materially false statements regarding the Revita DMR System.
Newpress release dated Sept 22, 2026
So whatLitigation of this type typically creates a multi-year overhang on the multiple and may necessitate a legal reserve on the balance sheet.
More negative than 79% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The lawsuit alleges that Fractyl executives used 'hype' from interim data to execute public offerings in August and September 2025, raising tens of millions of dollars.
Newpress release dated Sept 22, 2026
More negative than 71% of claims this week
Six-month data from the REMAIN-1 Midpoint Cohort showed Revita-treated patients experienced 4.5% weight regain vs 7.5% in the sham arm.
Priced indisclosed on January 29, 2026
So whatThis result, disclosed months prior, likely informs the current valuation and the probability of success for the subsequent Pivotal Cohort.
More negative than 66% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit alleging materially false and misleading statements regarding the efficacy of its Revita system.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
4h ago
—
GUTS hasn't traded since this ran. Last close $0.5530 (Sep 22); the reaction starts at the next open.
GUTS chart →